Plasma levels of fibrinolytic proteins and the risk of venous thrombosis

被引：0
|
作者：
Meltzer, M. E. [1 ,2 ]
Lisman, T. [2 ,3 ]
Meijers, J. C. M. [4 ]
de Groot, P. G. [2 ]
Doggen, C. J. M. [5 ]
Rosendaal, F. R. [6 ]
机构：
[1] Leiden Univ, Clin Epidemiol, Med Ctr, Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Clin Chem & Hematol, Utrecht, Netherlands
[3] Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Vasc Med & Expt Vasc Med, Amsterdam, Netherlands
[5] Leiden Univ, Clin Epidemiol, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands
[6] Leiden Univ, Clin Epidemiol Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC-WE-016
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [1] Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
    Lisman, T
    de Groot, PG
    Meijers, JCM
    Rosendaal, FR
    BLOOD, 2005, 105 (03) : 1102 - 1105
  • [2] Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis
    Lisman, Ton
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (02): : 178 - 184
  • [3] Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis.
    Lisman, T
    de Groot, PG
    Adelmeijer, J
    Meijers, JCM
    Rosendaal, FR
    BLOOD, 2004, 104 (11) : 711A - 711A
  • [4] Plasma levels of Midkine (neurite growth-promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis
    Lisman, T.
    Meltzer, M. E.
    Cannegieter, S. C.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) : 964 - 966
  • [5] Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
    Meltzer, M. E.
    Doggen, C. J. M.
    Meijers, J. C. M.
    de Groot, P. G.
    Rosendaal, F. R.
    Lisman, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 436 - 437
  • [6] Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
    Meltzer, Mirjam E.
    Doggen, Carine J. M.
    de Groot, Philip G.
    Rosendaal, Frits R.
    Lisman, Ton
    BLOOD, 2010, 116 (04) : 529 - 536
  • [7] Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
    Lisman, T.
    Meltzer, M. E.
    Meijers, J. C. M.
    de Groot, P. G.
    Doggen, C. J. M.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 : 23 - 23
  • [8] The Impact of the Fibrinolytic System on the Risk of Venous and Arterial Thrombosis
    Meltzer, Mirjam E.
    Doggen, Carine J. M.
    de Groot, Philip G.
    Rosendaal, Frits R.
    Lisman, Ton
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (05): : 468 - 477
  • [9] INFLUENCE OF DECREASED FIBRINOLYTIC ACTIVITY ON VENOUS THROMBOSIS RISK
    Vuckovic, B.
    Mitic, G.
    Djordjevic, V.
    THROMBOSIS RESEARCH, 2016, 141 : S47 - S48
  • [10] FIBRINOLYTIC THERAPY FOR VENOUS THROMBOSIS
    FRANCIS, CW
    MARDER, VJ
    PROGRESS IN CARDIOVASCULAR DISEASES, 1991, 34 (03) : 193 - 204
12345